Theoretical and Natural Science
- The Open Access Proceedings Series for Conferences
Theoretical and Natural Science
Vol. 20, 20 December 2023
Open
Access | Article
Epidemiology comparison and analysis of Alzheimer's disease in China and the United States
* Author to whom correspondence should be addressed.
Abstract
Alzheimer's disease is a prominent cause of dementia in late adulthood and is recognized as a progressive, multifaceted neurological illness. Studies of incidence and prevalence have a considerable influence on how much of a burden the community and healthcare system must bear. The author will compare and contrast the epidemiological states of Alzheimer's disease in China and the United States, explain their disparities, and offer suggestions for China's future. This paper analyzes the U.S.’s epidemiology situation, China’s epidemiology situation, and then makes a comparison with three aspects. Epidemiology in America includes its overview, the difference between symptom-based data and biomarker-based data, the forecasted increase in prevalence between 2020-2025 in the states, the incidence, and the race; China’s epidemiology describes the overview of China’s Alzheimer’s disease situation and regional studies. It is discovered that China’s decreasing mortality, Asian people’s prevalence are lower than white people, special regional research, and biomarker research are needed with which more research will be carried on.
Keywords
Alzheimer′s disease, dementia, epidemiology, prevalence, China
References
1. A. Kumar et al. (2015). A review on Alzheimer’s disease pathophysiology and its management: an update. Pharmacological Reports, 67, 195–203
2. Jiang, T., Sun, Q., and Chen, S. (2016). Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson’s disease and Alzheimer’s disease. Prog. Neurobiol. 147, 1–19.
3. Rajiah, K., Maharajan, M. K., Yeen, S. J., and Lew, S. (2017). Quality of life and caregivers’ burden of Parkinson’s disease. Neuroepidemiology 48, 131–137.
4. Henderson, C., Knapp, M., Nelis, S. M., Quinn, C., Martyr, A., Wu, Y. T., et al. (2019). Use and costs of services and unpaid care for people with mild-to-moderate dementia: baseline results from the IDEAL cohort study. Alzheimer’s Dement. 5, 685–696.
5. Cui L, Hou N-N, Wu H-M, Zuo X, Lian Y-Z, Zhang C-N, Wang Z-F, Zhang X and Zhu J-H. (2020).Prevalence of Alzheimer’s Disease and Parkinson’s Disease in China: An Updated Systematical Analysis. Front. Aging Neurosci. 12:603854.
6. Alzheimer’s Association. (2022). 2022 Alzheimer’s Disease Facts and Figures. Alzheimer’s Dement 2022;18.
7. Weuve J, Rajan KB, Barnes LL, Wilson RS, Evans DA. (2018). Secular trends in cognitive performance in older black and white U.S. adults, 1993-2012: Findings from the Chicago Health and Aging Project. J Gerontol B Psychol Sci Soc Sci 2018;73.
8. Hudomiet P, Hurd MD, Rohwedder S. (2019). The relationship between lifetime out-of-pocket medical expenditures, dementia and socioeconomic status in the U.S. J Econ Ageing 2019;14: 100181.
9. Hendriks S, Peetoom K, Bakker C, van der Flier WM, Papma JM, Koopmans R, et al. (2021). Global prevalence of young-onset dementia: A systematic review and meta-analysis. JAMA Neurol 2021;78(9):1080-90.
10. Kapasi A, DeCarli C, Schneider JA. (2017). Impact of multiple pathologies on the threshold for clinically overt dementia. Acta Neuropathol 2017;134(2):171-86.
11. Barnes LL, Leurgans S, Aggarwal NT, Shah RC, Arvanitakis Z, James BD, et al. (2019). Mixed pathology is more likely in black than white decedents with Alzheimer’s dementia. Neurology 2015;85:528-34.
12. Weuve J, Hebert LE, Scherr PA, Evans DA. Prevalence of Alzheimer’s disease in U.S. states. Epidemiology 2015;26(1): E4-6.
13. Rajan KB, Weuve J, Barnes LL, Wilson RS, Evans DA. (2019). Prevalence and incidence of clinically diagnosed Alzheimer's disease dementia from 1994 to 2012 in a population study. Alzheimer’s Dement 2019;15(1):1-7.
14. Mayeda ER, Glymour MM, Quesenberry CP, Whitmer RA. (2016). Inequalities in dementia incidence between six racial and ethnic groups over 14 years. Alzheimer’s Dement 2016;12(3):216-24.
15. Mayeda ER, Glymour MM, Quesenberry CP, Jr., Whitmer RA. (2017). Heterogeneity in 14-year dementia incidence between Asian American subgroups. Alzheimer Dis Assoc Disord 2017;31(3):181-6.
16. ZHANG Jing-ya*, LU Yong-bo, LI Hao-ran, et al. (2022). Disease burden of Alzheimer’s disease and other dementias in Chinese residents between 1990 and 2019: an age-period-cohort analysis and prediction. Chin J Public Health, 38(5), 523-528.
17. Jia, J., Wang, F., Wei, C., Zhou, A., Jia, X., Li, F., et al. (2014). The prevalence of dementia in urban and rural areas of China. Alzheimers Dement. 10, 1–9.
18. Gao, S., Hendrie, H. C., Hall, K. S., and Hui, S. (1998). The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis. Arch. Gen. Psychiatry 55, 809–815.
19. Wyss-Coray, T. (2016). Ageing, neurodegeneration and brain rejuvenation. Nature 539, 180–186.
20. Dubois, B., Hampel, H., Feldman, H. H., Scheltens, P., Aisen, P., Andrieu, S., et al. (2016). Preclinical Alzheimer’s disease: definition, natural history, and diagnostic criteria. Alzheimer’s Dement. 12, 292–323.
21. WANG Hai-ling, et al. (2022). Current situation and influencing factors of Alzheimer’s disease in the elderly aged 65 and above in Henan Province. Modern Preventive Medicine, 49(8), 1356-1360.
22. MA Yan-ru, Xu Yang, et al. (2022). Investigation on knowledge and cognition of Alzheimer's disease among 580 medical workers in Beijing. South China J Prev Med, 48(1), 125-127.
23. WANG Yan-ping, ZHAI Jing-bo, ZHU Fang, et al. (2011). Analysis of Alzheimer's disease and its influencing factors among elderly people in the community. Shanxi Medical University.
24. LIU Bo-yuan. (2018). Prevalence of Alzheimer's disease in areas of Yunnan Province. Kunming Medical University.
Data Availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open Access Instruction).
- Volume Title
- Proceedings of the 3rd International Conference on Biological Engineering and Medical Science
- ISBN (Print)
- 978-1-83558-213-8
- ISBN (Online)
- 978-1-83558-214-5
- Published Date
- 20 December 2023
- Series
- Theoretical and Natural Science
- ISSN (Print)
- 2753-8818
- ISSN (Online)
- 2753-8826
- DOI
- 10.54254/2753-8818/20/20230717
- Copyright
- 20 December 2023
- Open Access
- This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited